Michael Amoroso - 30 Sep 2021 Form 4 Insider Report for ABEONA THERAPEUTICS INC. (ABEO)

Role
Chief Executive Officer, Director
Signature
/s/ Michael Amoroso
Issuer symbol
ABEO
Transactions as of
30 Sep 2021
Net transactions value
-$49,382
Form type
4
Filing time
04 Oct 2021, 16:06:05 UTC
Next filing
19 Oct 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABEO Common stock Sale $49,382 -45,409 -7% $1.09 604,637 30 Sep 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were to cover tax obligations associated with vested restricted stock awards and were effected pursuant to a Rule 10b5-1 trading plan adopted by Michael Amoroso on February 24, 2021.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.08 to $1.11, inclusive. The reporting person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote.